Literature DB >> 2194821

Acute effects of antihypertensive agents on cerebral blood flow in hypertensive rats.

H Ooboshi1, S Sadoshima, K Fujii, H Yao, S Ibayashi, M Fujishima.   

Abstract

The acute effects of various antihypertensive agents on cerebral blood flow and mean arterial pressure (MAP) were studied in anesthetized (amobarbital 100 mg/kg) spontaneously hypertensive rats. Cerebral blood flow in the cortex and thalamus was measured by the hydrogen clearance method before and during a 60-min i.v. infusion of calcium antagonist (nifedipine), angiotensin converting enzyme inhibitor (captopril) or beta-blocker (propranolol). Nifedipine, 30 or 150 micrograms/kg per h, decreased dose dependently the MAP by 20 or 31%, and concomitantly increased cortical blood flow by 28 or 74%, and thalamic blood flow by 51 or 64%, respectively. Captopril, 10 or 100 mg/kg per h, decreased MAP by 7 or 14%, but changed cerebral blood flow minimally. In contrast, propranolol, 1.0 or 5.0 mg/kg per h, decreased MAP by 13 or 11%, with a concomitant reduction of cortical and thalamic blood flow by 20 or 15 and 33 or 37%, respectively. It is concluded that the changes in cerebral blood flow in response to hypotension are varied by antihypertensive drugs depending on the direct or indirect effect of the drugs (dilatation or constriction) on cerebral vessels. Nifedipine seems to dilate while propranolol constricts cerebral vessels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194821     DOI: 10.1016/0014-2999(90)90163-z

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

Review 1.  Angiotensin and cerebral blood flow.

Authors:  J M Saavedra; Y Nishimura
Journal:  Cell Mol Neurobiol       Date:  1999-10       Impact factor: 5.046

Review 2.  Central sympathoinhibitory effects of calcium channel blockers.

Authors:  F H Leenen; M Ruzicka; B S Huang
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

3.  Metoprolol Impairs β1-Adrenergic Receptor-Mediated Vasodilation in Rat Cerebral Arteries: Implications for β-Blocker Therapy.

Authors:  Christopher L Moore; David S Henry; Samantha J McClenahan; Kelly K Ball; Nancy J Rusch; Sung W Rhee
Journal:  J Pharmacol Exp Ther       Date:  2020-10-25       Impact factor: 4.030

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.